GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gufic Biosciences Ltd (NSE:GUFICBIO) » Definitions » Short-Term Debt

Gufic Biosciences (NSE:GUFICBIO) Short-Term Debt : ₹0 Mil (As of Dec. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Gufic Biosciences Short-Term Debt?

Gufic Biosciences's Short-Term Debt for the quarter that ended in Dec. 2024 was ₹0 Mil.

Gufic Biosciences's quarterly Short-Term Debt increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹1,408 Mil) but then declined from Sep. 2024 (₹1,408 Mil) to Dec. 2024 (₹0 Mil).

Gufic Biosciences's annual Short-Term Debt increased from Mar. 2022 (₹133 Mil) to Mar. 2023 (₹1,207 Mil) and increased from Mar. 2023 (₹1,207 Mil) to Mar. 2024 (₹1,631 Mil).


Gufic Biosciences Short-Term Debt Historical Data

The historical data trend for Gufic Biosciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gufic Biosciences Short-Term Debt Chart

Gufic Biosciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 971.98 199.22 132.64 1,207.28 1,630.71

Gufic Biosciences Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1,630.71 - 1,407.98 -

Gufic Biosciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Gufic Biosciences Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Gufic Biosciences's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Gufic Biosciences Business Description

Traded in Other Exchanges
Address
SM House, 11 Sahakar Road, 1st to 4th Floor, Vile Parle (East), Mumbai, MH, IND, 400 057
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare; Criticare Life; Ferticare; Spark; Herbal and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral and a proton-pump inhibitor. It derives maximum revenue from India.

Gufic Biosciences Headlines

No Headlines